Correlation Between Intellia Therapeutics and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Intellia Therapeutics and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Madrigal Pharmaceuticals.
Diversification Opportunities for Intellia Therapeutics and Madrigal Pharmaceuticals
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Intellia and Madrigal is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Intellia Therapeutics is expected to generate 1.17 times more return on investment than Madrigal Pharmaceuticals. However, Intellia Therapeutics is 1.17 times more volatile than Madrigal Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest 1,481 in Intellia Therapeutics on September 2, 2024 and sell it today you would earn a total of 81.00 from holding Intellia Therapeutics or generate 5.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Intellia Therapeutics |
| Madrigal Pharmaceuticals |
Intellia Therapeutics and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Madrigal Pharmaceuticals
The main advantage of trading using opposite Intellia Therapeutics and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |